June 14, 2024 USA
Beyond Biotech podcast – Looking to cure Type 1 diabetes
In the latest episode of the Beyond Biotech Podcast Anders Essen-Möller, founder of Diamyd Medical, talks about the company’s approach to tackling diabetes.
Listen to the podcast here
Diamyd Medical’s antigen-specific immunomodulator aiming to preserves insulin production is currently being evaluated in a confirmatory phase 3 trial.
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.